TerminatedNCT00554385
What is this study about?Researchers are studying ABT-089 to find out how it affects ADHD symptoms in children with ADHD.
This study ended early.
Multiple locations, including Little RockADHDMedication studyAges 6–12
- Countries
- United States
- Sponsor
- Abbott
CompletedNCT00119756
About this title
A Safety and Tolerability Study of Paliperidone Palmitate Injected in the Shoulder or the Buttock Muscle in Patients With Schizophrenia
Read the official source — NCT00119756What is this study about?This study evaluated the safety of paliperidone palmitate for people with schizophrenia.
This study has finished and is no longer accepting participants.
Location not clearly listedSchizophreniaMedication studyAges 18+
- Countries
- Sponsor
- Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
CompletedNCT00845026
What is this study about?Researchers compared LY2140023, aripiprazole, olanzapine and risperidone, tracking side effects to assess long-term safety and tolerability in people with schizophrenia.
This study has finished and is no longer accepting participants.
Multiple locations, including EscondidoSchizophreniaMedication studyAges 18–65
- Countries
- United States, Germany, Mexico, + 1 other
- Sponsor
- Denovo Biopharma LLC
CompletedNCT05233085
Official study titleA Randomized, Double-Blind, Placebo-Controlled Study to Assess the Safety, Tolerability, and Pharmacokinetics of Multiple Ascending Doses of AZD4041 in Healthy Adult Subjects
This study has finished and is no longer accepting participants.
In LavalAddictionMedication studyAges 18–55
- Countries
- Canada
- Sponsor
- AstraZeneca
CompletedNCT02476058
What is this study about?Researchers compared JNJ-42847922, Diphenhydramine and placebo, tracking side effects to assess safety and tolerability in people with depression.
This study has finished and is no longer accepting participants.
Multiple locations, including AalstDepressionMedication studyAges 18–64
- Countries
- Belgium, Germany, Netherlands
- Sponsor
- Janssen-Cilag International NV
CompletedNCT03565068
Official study titleA Multiple-dose Clinical Study to Evaluate the Safety, Tolerability, Pharmacokinetics and QTc Effect of MK-8189 in Participants With Schizophrenia and Healthy Participants.
This study has finished and is no longer accepting participants.
In GlendaleSchizophreniaMedication studyAges 18–60
- Countries
- United States
- Sponsor
- Merck Sharp & Dohme LLC
CompletedNCT01051531
What is this study about?Researchers studied Paliperidone palmitate to find out how it affected psychotic symptoms in people with schizophrenia.
This study has finished and is no longer accepting participants.
Multiple locations, including DandenongSchizophreniaMedication studyAges 18–50
- Countries
- Australia, New Zealand, China, + 5 others
- Sponsor
- Janssen Research & Development, LLC
CompletedNCT02205099
What is this study about?This study evaluated the safety of SKL15508 for people with schizophrenia.
This study has finished and is no longer accepting participants.
In GlendaleSchizophreniaMedication studyAges 18–60
- Countries
- United States
- Sponsor
- SK Life Science, Inc.
CompletedNCT05721235
Official study titleA Multicenter, Dose-Optimized, Open-Label, Safety/Tolerability and Pharmacokinetic Study With Azstarys® in Children 4 and 5 Years of Age With Attention-Deficit/Hyperactivity Disorder
This study has finished and is no longer accepting participants.
Multiple locations, including Little RockADHDMedication studyAges 4–5
- Countries
- United States
- Sponsor
- Corium, Inc.
CompletedNCT05506839
This study has finished and is no longer accepting participants.
In Ann ArborPTSD, Depression, ...Interventional studyAges 18+
- Countries
- United States
- Sponsor
- University of Michigan
CompletedNCT06026306
Official study titleA Pilot Randomized Controlled Trial of a Scalable Psychological Intervention for Enhancing Mental Health Outcomes Among Earthquake Survivors in Türkiye
This study has finished and is no longer accepting participants.
In IstanbulDepressionBehavioural studyAges 18+
- Countries
- Türkiye
- Sponsor
- Koç University
CompletedNCT04980326
Official study titleA Scalable Low-intensity Psychological Intervention to Reduce Psychological Distress Among Healthcare Workers Involved in the First COVID-19 Outbreak in Spain: a Randomized Trial
This study has finished and is no longer accepting participants.
Multiple locations, including Sant Boi de LlobregatAnxiety, DepressionBehavioural studyAges 18+
- Countries
- Spain
- Sponsor
- Instituto de Investigación Hospital Universitario La Paz